PhRMA Opponents Will Exploit Divisions In Medicare Rx Debate - Holmer
Executive Summary
PhRMA's political opponents will try to take advantage of differences among member companies during the debate over drug coverage for seniors, Pharmaceutical Research & Manufacturers of America President Alan Holmer warned during the association's annual meeting in Naples, Fla. March 30.
You may also be interested in...
PBM Rules Are Pivotal Point Of Medicare Rx Debate, Breaux Tells PhRMA
The structure of competition among PBMs is a key point for industry to weigh in on during the Medicare drug benefit debate, Sen. Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting March 31 in Naples, Fla.
PBM Rules Are Pivotal Point Of Medicare Rx Debate, Breaux Tells PhRMA
The structure of competition among PBMs is a key point for industry to weigh in on during the Medicare drug benefit debate, Sen. Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting March 31 in Naples, Fla.
PhRMA VP Bantham Is Association's Number Two Exec; Bello Leaving
PhRMA General Counsel Russel Bantham is adding the title of exec VP and taking on the role of the number two official in the Pharmaceutical Research & Manufacturers of America trade association.